SUMMARY Separate tolerance tests involving oral intake of the dipeptide, L-arginyl-L-aspartate, and of a corresponding free amino acid mixture, were carried out in a single type 2 cystinuric patient. Absorption of aspartate was within normal limits, whilst that of arginine was normal after the peptide but considerably reduced after the amino acid mixture. The results are compared with the increments of serum arginine found in eight normal subjects after the oral intake of the free amino acid mixture.
The products of protein digestion within the gut lumen are absorbed by two separate processes: active transport of free amino acids, and mucosal uptake of oligopeptides followed by their hydrolysis to free amino acids which are subsequently transported to the capillary portal blood. There is now considerable evidence that in Hartnup disease  Asatoor, Cheng, Edwards, Lant, Matthews, Milne, Navab, and Richards, 1970) , despite a grossly reduced active transport of many free amino acids, mucosal uptake of oligopeptides is within normal limits. Corresponding evidence in the closely allied disease, cystinuria, is less complete. Hellier, Perrett, and Holdsworth (1970) , using an isolated jejunal loop technique, showed that uptake of lysine from the dipeptide glycyl-lysine in a single cystinuric patient was more rapid than from a corresponding mixture of the two free amino acids. Asatoor, Crouchman, Harrison, Light, Loughridge, Milne, and Richards (1971) , using the oral tolerance method, found that there was no difference in the rate of lysine absorption in three cystinuric patients after oral ingestion of lysyl-glycine and of the equivalent free amino acids. Further observations using a casein meal suggested that use of an arginine-containing peptide would be more likely to give differing results in the two separate tolerance tests than if oligopeptides containing lysine were used. Owing to the reactivity of the guanidino group in the molecule, arginine
Received for publication 7 December 1971. peptides are difficult to prepare in pure and bulk supply. This paper presents evidence that arginine absorption by a single cystinuric patient was more rapid and complete from the dipeptide L-arginyl-Laspartate than from a corresponding amino acid mixture of free arginine and of aspartic acid.
Methods
The cystinuric patient was an inpatient for assessment of the need for penicillamine therapy to prevent further development of renal calculi. He was a memberof a cystinuric family in which children of the affected patients excreted both lysine and cystine in excess, and in the patients there was clear evidence of impaired lysine and arginine absorption from the gut. He was, therefore, a 'type 2' cystinuric by the classification of Rosenberg, Downing, Durant, and Segal (1966) . Tolerance tests using an equimolecular mixture of free lysine and of aspartic acid were carried out on the patient and on eight normal control subjects. A pure sample of L-arginyl-L-aspartate was obtained from commercial sources. The compound was chromatographically pure and after acid hydrolysis produced exactly the expected amounts of free arginine and of aspartic acid. Toxicity tests in rats at 10 times the dosage per kilogram body weight as used in the patient produced no adverse symptoms. It had been planned to repeat the dipeptide tolerance test in a normal control subject, but unfortunately a second batch of this dipeptide obtained from the same commercial 95 Dosage of both the peptide and of the amino acid mixture was 0.09 mmol/kg body weight, and each was taken by mouth dissolved in 500 ml water in the early morning, fasting state. Blood samples were obtained immediately before the oral dose, and at 15, 30, 45, 60, and 90 minutes thereafter. Urine specimens from the patient were collected at the following intervals: four hours immediately before the oral dose, 0-4 hours, 4-8 hours, 8-12 hours, and 12-22 hours after the dose. Similar specimens were not obtained from the controls as it has been previously shown that higher doses of arginine have no effect on urinary amine output in normal man (Asatoor, Lacey, London, and Milne, 1962) .
C'HEMICAL METHODS
Amino acids in serum Ion-exchange chromatography using the Technicon amino acid analyser (Technicon Handbook, 1966) .
Heterocyclic amines in urine
The method of Asatoor (1960) 
Diamines in urine
The procedure was repeated extraction by chloroform from an alkalinized specimen of urine corresponding to one-hour output, followed by transfer to N/10 HCI, evaporation to dryness under reduced pressure, and separation by thin-layer chromatography of the residue on silica gel plates (Merck), Figure 1 shows that the rise of serum arginine after ingestion of arginyl-aspartate by the cystinuric patient was considerably higher than after the intake of a corresponding free amino acid mixture. Increments of arginine after the peptide were almost identical with the mean increments of eight normal controls after ingestion of the mixture of arginine and aspartic acid. Aspartic acid is partly absorbed unchanged but a greater proportion is transaminated within the intestinal mucosal cells to alanine (Matthews and Wiseman, 1953) . Table I shows that increments of serum aspartate plus alanine are almost identical in the cystinuric patient after the peptide and the mixed amino acids, but were somewhat larger than the mean rise in normal controls after the amino acid mixture. The results of the oral tolerance tests suggest that the cystinuric patient absorbed arginine less efficiently from the free amino acids than from the dipeptide, but that aspartate transport was normal in both cases. This interpretation is supported by analysis of urinary pyrrolidine (Fig. 2) . Arginine, which is unabsorbed in the small intestine, is converted by colonic bacteria to pyrrolidine, and this is then partly absorbed and excreted unchanged in the urine (Asatoor et al, 1962) . Increase of urinary pyrrolidine is therefore a useful ancillary proof of arginine malabsorption in the small gut. The cystinuric patient investigated had a grossly raised basal pyrrolidine output (Fig. 2) , indicating reduced arginine absorption from the amount present in a . ~~~~R-6 Intestinal absorption of an arginine-containing peptide in cystinuria --r iP detection by the method used. In the 12-22-hour specimen, after the free amino acid mixture, the urinary output was 9 Hg per hour. Putrescine is an intermediate in the bacterial conversion of arginine to pyrrolidine, but after absorption is chiefly oxidized by diamine oxidase, and only a small fraction is excreted in the urine. By contrast, pyrrolidine is the end product of the reaction, and the whole of the amount absorbed is excreted unchanged.
Discussion al The present results, taken in conjunction with those Ln of a previous paper (Asatoor et al, 1971) , indicate if that arginine absorption in cystinuric patients is normal or only very slightly reduced from argininecontaining oligopeptides,-whereas transport of the free amino acid from the gut lumen is grossly depressed. It is difficult to obtain results which are statistically significant because cystinuria is a somewhat rare disease, and because pure arginine-containing oligopeptides are both expensive and in short supply. The previous results (Asatoor et al, 1971) suggested that tolerance tests using argininecontaining peptides were more likely to give different results in the two separate tolerance tests than corresponding tests using the more readily available peptides containing lysine. Free lysine seems to be absorbed satisfactorily from the gut of cystinuric patients when the amount of the amino acid is either equal to or only slightly above that of a normal protein diet. If, however, very large amounts of free lysine are given by mouth (Milne, Asatoor, Edwards, and Loughridge, 1961) (McCarthy, Borland, Lynch, Owen, and Tyor, 1964; Thier, Segal, Fox, Blair, and Rosenberg, 1965) . Both free arginine and free lysine are readily released from protein chains by the combined action of trypsin and carboxypeptidase B (Dixon and Webb, 1964) , and consequently the concentrations of these two amino acids within the gut lumen are higher than that of any of the other amino acids after intake of dietary protein.
Thus, Nixon and Mawer (1970) recorded a mean concentration of 700 ,umol/l free lysine and 350 ,tmol/l free arginine in jejunal aspirates after a milk feed. Obviously, therefore, in absorption of these amino acids from the gut lumen, active transport of the free amino acid as well as mucosal uptake of oligopeptides is probably quantitatively important. Lysine is an essential amino acid in man, whereas arginine is not. Cystinuric patients show no obvious nutritional defec., adequate absorption of lysine being assured both by uptake of lysine-containing oligopeptides and by some alternative method of transport of the free amino acid other than that of active transport. This alternative method must presumably be either facilitated or passive diffusion. By contrast, the large amounts of arginine released during digestion are inadequately absorbed, accounting for the increased amounts of faecal and urinary pyrrolidine found in many cystinuric patients. Fortunately, on an adequate protein intake, this degree of arginine malabsorption is of no nutritional significance. The results show that the use of urinary pyrrolidine is a more sensitive indicator of reduced arginine absorption than is analysis of tetramethylenediamine (putrescine) in urine samples. Concentrations of the diamine are usually very low because absorbed putrescine is mainly oxidized by diamine oxidase rather than by being eliminated in the urine. The observed concentrations of urinary diamine were similar to those recently reported in cystinuric patients by Bremer, Kohne, and Endres (1971) , and the rise after arginine intake suggests that, similarly to pyrrolidine, urinary putrescine in cystinuric patients is chiefly derived from the products of bacterial degradation of unabsorbed arginine within the colon.
The results of this paper would obviously have been more conclusive if it had been possible to carry out the tests on more than a single cystinuric patient, and if the peptide tolerance test could have been carried out in normal controls. In both instances limited supplies of pure peptide prevented these further tests being performed. It is, however, known that arginine absorption in the normal rat is less rapid from arginyl-aspartate than from an equivalent free amino acid mixture (Asatoor et al, 1971 ), a result the reverse of that found in the patient.
